Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Baycol documents subpoenaed

Executive Summary

FDA and Department of Defense initiate joint investigation into Bayer's withdrawn statin Baycol, company says in 1April 8 filing with Securities & Exchange Commission. Bayer received a subpoena for documents from the Defense Criminal Investigative Service in January. Bayer supplied Baycol (cerivastatin) under contract to the DoD prior to the withdrawal of the cholesterol-lowering agent in August 2001. Merck's Zocor was the only other statin on formulary at the time of the withdrawal...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS043703

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel